Management of pulmonary disease in patients with cystic fibrosis.
Ramsey
B W
BW
Department of Pediatrics, University of Washington School of Medicine, Seattle 98195, USA.
D042462:4-Quinolones; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D015316:Genetic Therapy; D006801:Humans; D008171:Lung Diseases / Q000209:etiology / Q000628:therapy*; D026741:Physical Therapy Modalities
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents